Correlation Between Zentalis Pharmaceuticals and Zymeworks Common
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Zymeworks Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Zymeworks Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Zymeworks Common Stock, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Zymeworks Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Zymeworks Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Zymeworks Common.
Diversification Opportunities for Zentalis Pharmaceuticals and Zymeworks Common
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Zentalis and Zymeworks is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Zymeworks Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zymeworks Common Stock and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Zymeworks Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zymeworks Common Stock has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Zymeworks Common go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Zymeworks Common
Given the investment horizon of 90 days Zentalis Pharmaceuticals is expected to generate 1.06 times less return on investment than Zymeworks Common. In addition to that, Zentalis Pharmaceuticals is 2.01 times more volatile than Zymeworks Common Stock. It trades about 0.06 of its total potential returns per unit of risk. Zymeworks Common Stock is currently generating about 0.12 per unit of volatility. If you would invest 1,152 in Zymeworks Common Stock on September 3, 2024 and sell it today you would earn a total of 257.00 from holding Zymeworks Common Stock or generate 22.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Zymeworks Common Stock
Performance |
Timeline |
Zentalis Pharmaceuticals |
Zymeworks Common Stock |
Zentalis Pharmaceuticals and Zymeworks Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zentalis Pharmaceuticals and Zymeworks Common
The main advantage of trading using opposite Zentalis Pharmaceuticals and Zymeworks Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Zymeworks Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zymeworks Common will offset losses from the drop in Zymeworks Common's long position.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Zymeworks Common vs. Day One Biopharmaceuticals | Zymeworks Common vs. Inozyme Pharma | Zymeworks Common vs. Zentalis Pharmaceuticals Llc | Zymeworks Common vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |